Takeda Chief Says Acquisitions Altered Firm’s Japanese Business Ways
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals is largely abandoning its Japanese way of doing business and adopting an international approach that relies on English and a greater vision and clarity of presenting ideas.